Radiation Oncology/Therapy: Page 21

Guerbet, Merative shift terms of collaboration

By AuntMinnie.com staff writers

Contrast agent developer Guerbet and partner Merative have shifted the terms of their collaboration.

November 3, 2022

MIM Software secures Health Canada clearance for AI software

By AuntMinnie.com staff writers

MIM Software has secured clearance from Health Canada for its artificial intelligence (AI) autocontouring software, Contour ProtégéAI.

October 31, 2022

Accuray applies for Tomo C Chinese market clearance

By AuntMinnie.com staff writers

Radiation therapy developer Accuray has applied to the Chinese National Medical Products Administration for market clearance for its Tomo C radiation therapy system.

October 31, 2022

PET/CT bests ultrasound for imaging malignant melanoma

By Will Morton

F-18 FDG-PET/CT imaging is a better choice than ultrasound for detecting both lymph node and abdominal metastases in patients with malignant melanoma, Swiss investigators have found.

October 31, 2022

SpectronRx names new COO

By AuntMinnie.com staff writers

Contract development and manufacturing organization SpectronRx has appointed Peter Webner as its new chief operating officer (COO).

October 30, 2022

ASTRO: Shorter irradiation effective for breast cancer treatment

By Amerigo Allegretto

A three-week radiation therapy course is as safe and effective as conventional treatment for early-stage breast cancer patients at higher risk of tumor recurrence, results presented at the American Society for Radiology Oncology (ASTRO) meeting show.

October 25, 2022

ASTRO: Therapy combo may slow growth of prostate cancer

By Will Morton

Prostate cancer patients who receive radiation in addition to intermittent hormone therapy may live longer without their disease progressing, according to a talk at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 25, 2022

First patient dosed with CD8 ImmunoPET in ImaginAb clinical trial

By AuntMinnie.com staff writers

The first patient has been dosed in a clinical trial assessing immuno-PET developer ImaginAb's PET/CT imaging agent CD8 ImmunoPET.

October 24, 2022

ASTRO: Radiation therapy boosts survival rate from liver cancer

By Kate Madden Yee

Combining radiation therapy and chemotherapy to treat patients with advanced liver cancer lengthens overall survival, according to research presented on October 24 at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 24, 2022

IBA expands use of myQA iON software to radiation therapy

By AuntMinnie.com staff writers

At the American Society for Radiation Oncology annual meeting in San Antonio, proton therapy developer Ion Beam Application (IBA) is highlighting expanded use of its myQA iON software to include linac-based radiotherapy.

October 23, 2022

ASTRO: AI model predicts hospitalizations in outpatient cancer patients

By Will Morton

An artificial intelligence (AI) model trained on fitness tracker data can predict if patients undergoing chemoradiation may need hospitalization, according to a talk at the American Society for Radiation Oncology (ASTRO) annual meeting.

October 23, 2022

ASTRO: PSA screening rates drop, prostate cancer incidence rises

By Amerigo Allegretto

Prostate-specific antigen (PSA) screening rates declined between 2008 and 2019 at the U.S. Veterans Healthcare Administration, according to a study at the American Society for Radiation Oncology (ASTRO) 2022 annual meeting in San Antonio.

October 23, 2022

Previous Page

Page 21 of 466

Next Page